Hs Pharma Email & Phone Number

HS Pharma focuses on non-toxic, ultra-low-adverse effect molecules with targeted anti-cancer activity. We draw on known Absorption, Distribution & Metabolism profiles of small molecules for which we have new insights into anti-cancer activity. Hence we have moved from the traditional model that identifies highly toxic anti-cancer agents and then understands their maximum tolerated dose, to one that finds well metabolized, ultra safe molecules that can be administered without effect at very high dose whilst targeting cancers and cancerous cells. The company has a particular interest in the unmet need of treatment of disseminating and metastatic cancers but evidence also of efficacy in solid tumors. Whilst work is currently at the pre-clinical stage, drawing on a range of cancer models, we are finalizing formulation and further tests of our lead molecule; and anticipate human cancer studies to be ready for 2014.

Listed skills include Fundraising, Research, Cancer Research, Philanthropy, and 3 others.

• 

  Company

  Hs Pharmaceuticals, Llc

  Jan 2001 - Present

  HS Pharmaceuticals, LLC is an early stage drug development company focusing on innovative immunotherapies for cancer treatment. Current pipeline programs include pre-clinical stage compounds for melanoma, pancreatic, breast, and lung cancers.HS Pharma’s novel, proprietary, patented compound HS-7, is an orally available small molecule that also lends itself to IV systemic delivery with demonstrated safety and efficacy in animal models. The company is seeking US and international development partners.The company has a streamlined operational structure and utilizes best in class academic research labs, CRO’s and industry experts to cost effectively advance its technology through the pre-clinical development process and into clinical trials.